Abiopharma

New Form 8-K - BioSig Technologies, Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026853 Size: 467 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Notification from CorMedix Inc.

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

New Form 144 - Twist Bioscience Corp Filed: 2025-09-08 AccNo: 0001959173-25-005838 Size: 7 KB

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH

New Form 144 - Century Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001959173-25-005837 Size: 5 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-09-08 AccNo: 0001959173-25-005836 Size: 6 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-09-08 AccNo: 0001959173-25-005835 Size: 6 KB

New Form 144 - Twist Bioscience Corp Filed: 2025-09-08 AccNo: 0001959173-25-005833 Size: 6 KB

New Form 144 - Century Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001959173-25-005831 Size: 5 KB

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

Director CROTEAU DANIEL C 🔴 sold 2.9K shares of UFP TECHNOLOGIES INC (UFPT) at $206.04 Transaction Date: Sep 05, 2025 | Filing ID: 000002

New Form 144 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-09-08 AccNo: 0001959173-25-005829 Size: 5 KB

IFF expande a unidade da LMR Naturals em Grasse, avançando a liderança em inovação em produtos naturais

IFF、グラースのLMR Naturals拠点を拡張し、天然素材のイノベーションにおけるリーダーシップを推進